六、终末期肾病的死亡原因 - Suppr

Suppr

超能文献

VI. Causes of death in ESRD.

出版信息

Am J Kidney Dis. 1999 Aug;34(2 Suppl 1):S87-94. doi: 10.1053/AJKD034s00087.

DOI:10.1053/AJKD034s00087

PMID:10431005

Abstract

摘要

相似文献

VI. Causes of death in ESRD.

Am J Kidney Dis. 1999 Aug;34(2 Suppl 1):S87-94. doi: 10.1053/AJKD034s00087.

Mortality in chronic kidney disease and renal replacement therapy: a population-based cohort study.

BMJ Open. 2014 Feb 18;4(2):e004251. doi: 10.1136/bmjopen-2013-004251.

[Dialysis and transplantation report of the Spanish Nephrology Society and Autonomous Registries for the year 2000].

Nefrologia. 2002;22(4):310-7.

Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada.

Nephrol Dial Transplant. 2012 Sep;27(9):3568-75. doi: 10.1093/ndt/gfr674. Epub 2012 Mar 5.

Survival comparisons between haemodialysis and peritoneal dialysis.

Nephrol Dial Transplant. 2012 Sep;27(9):3385-7. doi: 10.1093/ndt/gfs031. Epub 2012 Mar 6.

The effect of timing of the first kidney transplantation on survival in children initiating renal replacement therapy.

Nephrol Dial Transplant. 2012 Mar;27(3):1256-64. doi: 10.1093/ndt/gfr493. Epub 2011 Aug 23.

Seasonal variations in cause-specific mortality and transition to renal replacement therapy among patients with end-stage renal disease.

Sci Rep. 2020 Feb 11;10(1):2325. doi: 10.1038/s41598-020-59153-6.

Survival analysis of pediatric dialysis patients in Taiwan.

Nephrology (Carlton). 2012 Sep;17(7):621-7. doi: 10.1111/j.1440-1797.2012.01613.x.

Chronic peritoneal dialysis in Turkish children: a multicenter study.

Pediatr Nephrol. 2005 May;20(5):644-51. doi: 10.1007/s00467-004-1773-9. Epub 2005 Feb 17.

Comparative mortality risks of chronic dialysis and cadaveric transplantation in black end-stage renal disease patients.

Am J Kidney Dis. 1994 Jul;24(1):59-64. doi: 10.1016/s0272-6386(12)80160-0.

引用本文的文献

Identification of Novel Non-secosteroidal Vitamin D Receptor Agonists with Potent Cardioprotective Effects and devoid of Hypercalcemia.

Sci Rep. 2017 Aug 16;7(1):8427. doi: 10.1038/s41598-017-08670-y.

Decreased Serum 25-hydroxyvitamin D Level Causes Interventricular Septal Hypertrophy in Patients on Peritoneal Dialysis: Cardiovascular Aspects of Endogenous Vitamin D Deficiency.

Int J Nephrol. 2016;2016:2464953. doi: 10.1155/2016/2464953. Epub 2016 Nov 27.

The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection.

Clin Interv Aging. 2013;8:149-56. doi: 10.2147/CIA.S38349. Epub 2013 Feb 11.

Suboptimal medical care of patients with ST-elevation myocardial infarction and renal insufficiency: results from the Korea Acute Myocardial Infarction Registry.

BMC Nephrol. 2012 Sep 11;13:110. doi: 10.1186/1471-2369-13-110.

Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats.

J Card Fail. 2011 Dec;17(12):1051-8. doi: 10.1016/j.cardfail.2011.08.006. Epub 2011 Sep 9.

Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats.

Cardiovasc Res. 2011 Sep 1;91(4):632-9. doi: 10.1093/cvr/cvr133. Epub 2011 May 11.

Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis.

Blood. 2010 Jul 29;116(4):631-9. doi: 10.1182/blood-2010-01-264051. Epub 2010 Apr 27.

Pathogenesis of vascular calcification in dialysis patients.

Clin Exp Nephrol. 2005 Dec;9(4):265-270. doi: 10.1007/s10157-005-0385-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验